Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tolerability and Safety of Nano-Tocotrienols in Healthy Individuals and Type 2 Diabetes
NCT07888426Phase 2Not yet recruiting
- Sponsor
- Universiti Malaya
- Start
- Oct 2026
- Primary completion
- Oct 2029
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of nano-tocotrienols in type 2 diabetes mellitus (T2DM) (6 arms), sponsored by Universiti Malaya. Primary endpoint: Number of events where safety biomarkers fall out of clinically acceptable ranges at 24 weeks. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
nano-tocotrienols
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT07888426.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07888426.